ArticlePharmacological reports : PR2025

Safety of dapagliflozin and empagliflozin in cases with diabetes mellitus or/and heart failure: a retrospective pharmacovigilance study conducted on the eudravigilance database.

Annamaria Mascolo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.